China Urges Local Drug Administrators To Stiffen Oversight
This article was originally published in PharmAsia News
Chinese authorities urged local food and drug administrations in the country to step up their supervision of drugs and food after suspending the licenses of 523 drug makers for illegal stimulants. The State FDA cracked down nationwide before the recent Olympics to ensure that athletes would not have access to stimulants and other performance-enhancing drugs. In the sweep SFDA and the State Administration for Industry and Commerce inspected all firms licensed to produce or sell stimulants, including 63,000 chemical plants, 13,000 wholesalers and 341,000 retailers. They also cited 45 chemical plants for other illegalities. (Click here for more
You may also be interested in...
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.
US regulators refused to accept the file for one of Y-mAbs's neuroblasoma drugs – omburtamab – in October but have given the green light to a second one, naxitamab.